Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta.
Kastrup M, von Heymann C, Hotz H, et al.
Ann Thorac Surg 2002;74(3):910-912.
NATA Rating :
Review by :
This is another case report on the efficacy of Novoseven in controlling severe bleeding in cardiac surgery. Post-operative bleeding continued in spite of the use of blood products and aprotinin infusion, but stopped after a single dose of rFVIIa. Coronary catheterization performed after giving rFVIIa showed good aortic prosthetic function and no alteration in the coronary arteries.
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.